Controlled Sedation with Alphaxalone-AlphadoloneBr Med J 1974; 2 doi: https://doi.org/10.1136/bmj.2.5920.656 (Published 22 June 1974) Cite this as: Br Med J 1974;2:656
- M. A. E. Ramsay,
- T. M. Savege,
- B. R. J. Simpson,
- R. Goodwin
Alphaxalone-alphadolone (Althesin), diluted and administered as a controlled infusion, was used as a sedative for 30 patients in an intensive therapy unit. This technique allowed rapid and accurate control of the level of sedation. It had three particularly useful applications: it provided “light sleep,” allowed rapid variation in the level of sedation, and enabled repeated assessment of the central nervous system.
Sedation was satisfactory for 86% of the total time, and no serious complications were attributed to the use of the drug. Furthermore, though alphaxalone-alphadolone was given for periods up to 20 days there was no evidence of tachyphylaxis or delay in recovery time.